373 results on '"Abraham, William T."'
Search Results
2. Left Atrial Improvement in Patients With Secondary Mitral Regurgitation and Heart Failure
3. Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping
4. Relationship between Sex, Body Size, and Cardiac Resynchronization Therapy Benefit: A Patient Level Meta-Analysis of Randomized Controlled Trials
5. Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction
6. Cross-Validation of Risk Scores for Patients Undergoing Transcatheter Edge-to-Edge Repair for Mitral Regurgitation
7. Changes in Left Ventricular Function and Outcomes After Trancatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation
8. Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis
9. Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies
10. Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure
11. PO-02-027 RELATIONSHIP BETWEEN SEX, BODY SIZE, AND CRT BENEFIT: A PATIENT LEVEL META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
12. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation
13. Functional and Symptomatic Clinical Trial Endpoints
14. Development of a New Technique for Ultrasound Imaging of the Innominate Vein and the Venous Angle
15. Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure
16. Prediction of Death or HF Hospitalization in Patients With Severe FMR
17. Functional Mitral Regurgitation Staging and its Relationship to Outcomes in the COAPT Trial
18. Minimally Clinically Important Difference in Health Status Scores in Patients With HFrEF vs HFpEF
19. Clinical Outcomes Related to Background Diuretic Use and New Diuretic Initiation in Patients With HFrEF
20. The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients With Heart Failure
21. PO-628-08 RESPONSE TO CRT IS DIFFERENT IN PATIENTS WITH IVCD COMPARED TO RBBB: A PATIENT LEVEL META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
22. PO-688-07 IMPACT OF BASELINE PR INTERVAL ON RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF FIVE RANDOMIZED TRIALS
23. The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies
24. A Novel Approach Using Remote Speech Analysis In Chronic Ambulatory Heart Failure Patients Allows Early Detection Of Clinical Decompensation Leading To Hospitalization Or Unplanned Iv Diuretics Treatment - Updated New Data
25. FUNCTIONAL AND SYMPTOMATIC CLINICAL ENDPOINTS IN HEART FAILURE RESEARCH: INSIGHTS FROM THE HEART FAILURE COLLABORATORY (HFC) - ACADEMIC RESEARCH CONSORTIUM (ARC) SCIENTIFIC EXPERT PANEL
26. INCIDENCE AND PROGNOSIS OF WORSENING RENAL FUNCTION IN PATIENTS WITH HEART FAILURE AND SECONDARY MITRAL REGURGITATION: THE COAPT TRIAL
27. Cardiac Pulmonary Nerve Stimulation (CPNSTM)
28. Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials
29. Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial
30. Age-Related Outcomes After Transcatheter Mitral Valve Repair in Patients With Heart Failure
31. Remote Speech Analysis in the Evaluation of Hospitalized Patients With Acute Decompensated Heart Failure
32. Direct Interstitial Decongestion in an Animal Model of Acute-on-Chronic Ischemic Heart Failure
33. Pulmonary Artery Pressure Monitoring Effectively Guides Management to Reduce Heart Failure Hospitalizations in Obesity
34. Cardiac Resynchronization Therapy and Cardiac Contractility Modulation in Patients with Advanced Heart Failure
35. Prognostic Importance of Health Status Versus Functional Status in Heart Failure and Secondary Mitral Regurgitation
36. Sex-Specific Outcomes of Transcatheter Mitral-Valve Repair and Medical Therapy for Mitral Regurgitation in Heart Failure
37. Left Ventricular Global Longitudinal Strain as a Predictor of Outcomes in Patients with Heart Failure with Secondary Mitral Regurgitation: The COAPT Trial
38. Device Therapy in Chronic Heart Failure
39. Impact of Diabetes on Outcomes After Transcatheter Mitral Valve Repair in Heart Failure
40. Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials
41. Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation
42. 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure
43. Treatment of HF in an Era of Multiple Therapies
44. The Use of MitraClip in Secondary Mitral Regurgitation and Heart Failure
45. Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation
46. Kidney Function After Initiation And Discontinuation Of Empagliflozin (EMPA) In Heart Failure (HF) Patients (Pts) With And Without Type 2 Diabetes (T2D): Insights From The Emperial Trials
47. Impact of COPD on Outcomes After MitraClip for Secondary Mitral Regurgitation
48. Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium
49. Cardiac safety research consortium “shock II” think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock
50. Conduct of Clinical Trials in the Era of COVID-19
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.